Methadone and heroin antinociception

Predominant δ-opioid-receptor responses in methadone-tolerant mice

Jodie J. Rady, Philip S. Portoghese, James M. Fujimoto

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Antinociceptive tail flick responses to heroin and 6-monoacetylmorphine mediated in the brain by μ-opioid receptor are switched by morphine pellet implantation to δ1- and δ2-opioid-receptors mediation, respectively. Present results showed that the μ-receptor response (inhibited by β-funaltrexamine) to methadone was changed by morphine pellet implantation to δ1 (inhibited by 7-benzylidenenaltrexone)- and δ2 (inhibited by naltriben)-opioid-receptor responses. Methadone pellet implantation likewise changed mediation from μ- to δ-opioid receptors for heroin and methadone but not for morphine (β-funaltrexamine continued to inhibit). Methadone μ action in the brain was linked through a descending system to activate spinal serotonin receptors (inhibited by methysergide), but this link was gone in the methadone-pellet-implanted group. In the latter group, the new δ1- and δ2-receptor responses were mediated by spinal GABAA (inhibited by bicuculline) and GABAB (inhibited by 2-hydroxysaclofen) receptors. These shifts in neuronal systems meant that μ receptors on a given neuron were not changed into δ receptors. Preliminary results showed that δ-agonist action for methadone was prevented from appearing by MK801, a NMDA-receptor antagonist, and did not occur in 129S6/SvEv mice which lack NMDA responsiveness. Could methadone maintenance treatment in humans uncover δ-agonist actions?

Original languageEnglish (US)
Pages (from-to)319-331
Number of pages13
JournalJapanese Journal of Pharmacology
Volume88
Issue number3
DOIs
StatePublished - Apr 23 2002

Fingerprint

Methadone
Heroin
Opioid Receptors
Morphine
Methysergide
Bicuculline
Serotonin Receptors
Brain
N-Methylaspartate
N-Methyl-D-Aspartate Receptors
Tail
Neurons

Keywords

  • Antinociception
  • Chronic methadone
  • Heroin
  • Methadone
  • δ-Opioid receptor

Cite this

Methadone and heroin antinociception : Predominant δ-opioid-receptor responses in methadone-tolerant mice. / Rady, Jodie J.; Portoghese, Philip S.; Fujimoto, James M.

In: Japanese Journal of Pharmacology, Vol. 88, No. 3, 23.04.2002, p. 319-331.

Research output: Contribution to journalArticle

@article{08b4cd64b27e4a939e46e623abde5c2d,
title = "Methadone and heroin antinociception: Predominant δ-opioid-receptor responses in methadone-tolerant mice",
abstract = "Antinociceptive tail flick responses to heroin and 6-monoacetylmorphine mediated in the brain by μ-opioid receptor are switched by morphine pellet implantation to δ1- and δ2-opioid-receptors mediation, respectively. Present results showed that the μ-receptor response (inhibited by β-funaltrexamine) to methadone was changed by morphine pellet implantation to δ1 (inhibited by 7-benzylidenenaltrexone)- and δ2 (inhibited by naltriben)-opioid-receptor responses. Methadone pellet implantation likewise changed mediation from μ- to δ-opioid receptors for heroin and methadone but not for morphine (β-funaltrexamine continued to inhibit). Methadone μ action in the brain was linked through a descending system to activate spinal serotonin receptors (inhibited by methysergide), but this link was gone in the methadone-pellet-implanted group. In the latter group, the new δ1- and δ2-receptor responses were mediated by spinal GABAA (inhibited by bicuculline) and GABAB (inhibited by 2-hydroxysaclofen) receptors. These shifts in neuronal systems meant that μ receptors on a given neuron were not changed into δ receptors. Preliminary results showed that δ-agonist action for methadone was prevented from appearing by MK801, a NMDA-receptor antagonist, and did not occur in 129S6/SvEv mice which lack NMDA responsiveness. Could methadone maintenance treatment in humans uncover δ-agonist actions?",
keywords = "Antinociception, Chronic methadone, Heroin, Methadone, δ-Opioid receptor",
author = "Rady, {Jodie J.} and Portoghese, {Philip S.} and Fujimoto, {James M.}",
year = "2002",
month = "4",
day = "23",
doi = "10.1254/jjp.88.319",
language = "English (US)",
volume = "88",
pages = "319--331",
journal = "Japanese Journal of Pharmacology",
issn = "0021-5198",
publisher = "Japanese Pharmacological Society",
number = "3",

}

TY - JOUR

T1 - Methadone and heroin antinociception

T2 - Predominant δ-opioid-receptor responses in methadone-tolerant mice

AU - Rady, Jodie J.

AU - Portoghese, Philip S.

AU - Fujimoto, James M.

PY - 2002/4/23

Y1 - 2002/4/23

N2 - Antinociceptive tail flick responses to heroin and 6-monoacetylmorphine mediated in the brain by μ-opioid receptor are switched by morphine pellet implantation to δ1- and δ2-opioid-receptors mediation, respectively. Present results showed that the μ-receptor response (inhibited by β-funaltrexamine) to methadone was changed by morphine pellet implantation to δ1 (inhibited by 7-benzylidenenaltrexone)- and δ2 (inhibited by naltriben)-opioid-receptor responses. Methadone pellet implantation likewise changed mediation from μ- to δ-opioid receptors for heroin and methadone but not for morphine (β-funaltrexamine continued to inhibit). Methadone μ action in the brain was linked through a descending system to activate spinal serotonin receptors (inhibited by methysergide), but this link was gone in the methadone-pellet-implanted group. In the latter group, the new δ1- and δ2-receptor responses were mediated by spinal GABAA (inhibited by bicuculline) and GABAB (inhibited by 2-hydroxysaclofen) receptors. These shifts in neuronal systems meant that μ receptors on a given neuron were not changed into δ receptors. Preliminary results showed that δ-agonist action for methadone was prevented from appearing by MK801, a NMDA-receptor antagonist, and did not occur in 129S6/SvEv mice which lack NMDA responsiveness. Could methadone maintenance treatment in humans uncover δ-agonist actions?

AB - Antinociceptive tail flick responses to heroin and 6-monoacetylmorphine mediated in the brain by μ-opioid receptor are switched by morphine pellet implantation to δ1- and δ2-opioid-receptors mediation, respectively. Present results showed that the μ-receptor response (inhibited by β-funaltrexamine) to methadone was changed by morphine pellet implantation to δ1 (inhibited by 7-benzylidenenaltrexone)- and δ2 (inhibited by naltriben)-opioid-receptor responses. Methadone pellet implantation likewise changed mediation from μ- to δ-opioid receptors for heroin and methadone but not for morphine (β-funaltrexamine continued to inhibit). Methadone μ action in the brain was linked through a descending system to activate spinal serotonin receptors (inhibited by methysergide), but this link was gone in the methadone-pellet-implanted group. In the latter group, the new δ1- and δ2-receptor responses were mediated by spinal GABAA (inhibited by bicuculline) and GABAB (inhibited by 2-hydroxysaclofen) receptors. These shifts in neuronal systems meant that μ receptors on a given neuron were not changed into δ receptors. Preliminary results showed that δ-agonist action for methadone was prevented from appearing by MK801, a NMDA-receptor antagonist, and did not occur in 129S6/SvEv mice which lack NMDA responsiveness. Could methadone maintenance treatment in humans uncover δ-agonist actions?

KW - Antinociception

KW - Chronic methadone

KW - Heroin

KW - Methadone

KW - δ-Opioid receptor

UR - http://www.scopus.com/inward/record.url?scp=0036218366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036218366&partnerID=8YFLogxK

U2 - 10.1254/jjp.88.319

DO - 10.1254/jjp.88.319

M3 - Article

VL - 88

SP - 319

EP - 331

JO - Japanese Journal of Pharmacology

JF - Japanese Journal of Pharmacology

SN - 0021-5198

IS - 3

ER -